Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment.

Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment. Curr Vasc Pharmacol. 2017 Dec 04;: Authors: Katsiki N, Imprialos K, Vlachopoulos C Abstract Arterial stiffness, central haemodynamics and non-alcoholic fatty liver disease (NAFLD) have been associated with increased risk for cardiovascular (CV) morbidity and mortality. Antihypertensive, antidiabetic and hypolipidaemic drugs may affect these predictors of CV risk. Such associations should be taken into consideration when treating high-risk patients. PMID: 29210656 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29210656?dopt=Abstract

Source: Current Vascular Pharmacology - December 4, 2017 Category: Drugs & Pharmacology Authors: Katsiki N, Imprialos K, Vlachopoulos C Tags: Curr Vasc Pharmacol Source Type: research